- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
CDSCO Warns Against 2 Beauty Creams Over Excessive Heavy Metals

The CDSCO said the products had not been issued registration certificates by the competent authority for import and sale in India. It warned that the excessive heavy metals may pose health risks to consumers, including toxic effects.
In its public notice, the CDSCO said cosmetic products used by consumers must be safe. It stated that the manufacture and import of cosmetics are regulated under the Drugs and Cosmetics Act, 1940, and the Cosmetics Rules, 2020, while standards for cosmetic products are published by the Bureau of Indian Standards. A licence from the State Licensing Authority is required to manufacture cosmetics for sale and distribution, and imported cosmetics must be registered with the Central Licensing Authority.
The CDSCO advised consumers not to purchase the two named products and not to use them or similarly named cosmetic products if already purchased.It also advised the public to purchase and use authorised cosmetics bearing the manufacturing licence number, manufacturer’s details, batch number, manufacturing and expiry dates, and, in the case of imported cosmetics, the registration number. Labelling violations should be reported to the respective State Drugs Controller for products manufactured in India and to the Drugs Controller General (India) for imported products, the notice said.
The notice stated that the products are unauthorised and contatns excessive heavy metals beyondthe specified limits which may pose health risk to the consumers including toxic effects
ln light of the above unauthorised cosmetics products, consumers are advised to:
- Not to purchase above mentioned cosmetics products
- Not to use such & similar named cosmetic products if purchased
Further, the members of the public are also advised to:
-Purchase & use authorised cosmetics products containing details of manufacturing license number, manufacturer's details, batch number, date of. manufacturing & expiry and Registration number (in case of imported cosmetics)
-ln case of violations observed in label, report it to the respective State Drugs Controller (for the products manufactured in lndia) and the Drugs Controller General (lndia) (for the imported cosmetics products).
Furthermore, the alert stated that the CDSCO warned establishments and individuals not to sell, distribute or advertise the named products. It also requested regulatory enforcement units to ensure that such unauthorised cosmetics are not sold in their jurisdictions.
To view the official notice, click the link below:
Mpharm (Pharmacology)
Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

